The effect of Ondansetron on prevention of Ventilator associated pneumonia in IC
Not Applicable
- Conditions
- Pneumonia.Pneumonia in diseases classified elsewhere
- Registration Number
- IRCT201406156480N6
- Lead Sponsor
- Vice chancellor for research, shahrekord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
patients aged 15-65 years; with the full consent of the patient protector; the patient respiratory support with ventilation; more than 48 hours hospitalization in the ICU
Exclusion criteria: patients out of the age range 15-65 years; patients with suspected pulmonary health is arrival; the lack of satisfaction of the patient protector.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ventilator associated pneumonia. Timepoint: Before and 5 days after the intervention, once a day. Method of measurement: Chek list (based on clinical symptoms and laboratory).
- Secondary Outcome Measures
Name Time Method Fever over 38 ° C without any known other infectious focus. Timepoint: Before and 5 days after the intervention, once a day. Method of measurement: Clinical signs.;Leukopenia. Timepoint: Before and 5 days after the intervention, once a day. Method of measurement: Lab data.;Purulent sputum. Timepoint: Before and 5 days after the intervention, once a day. Method of measurement: Clinical signs.;Create new cough or worsening cough previous or shortness of breath or increased respiratory rate. Timepoint: Before and 5 days after the intervention, once a day. Method of measurement: Clinical signs.;Disruption of blood gases. Timepoint: Before and 5 days after the intervention, once a day. Method of measurement: Lab data.